pharma · Nicotine use
SWEDISH ORPHAN BIOVITRUM
Swedish Orphan Biovitrum Pty Ltd
Swedish Orphan Biovitrum is a pharma organization headquartered in AU. Primary therapeutic focus areas include Nicotine use. NovaPharmaNews links 2 clinical program(s), 3 drug profile(s), and 0 patent record(s) to this e
IT HQ
3 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- IT
- Employees
- 3
- Programs
- 2
- Drugs
- 10
- Patents
- 0
SM25-01
Phase 1 · other · Nicotine use
SM25-01 for Nicotine use is a Phase 1 program (other) at Swedish Orphan Biovitrum Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code SM25-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Swedish Orphan Biovitrum Pty Ltd
- Phase
- Phase 1
- Modality
- other
- Indication
- Nicotine use
- Status
- active
- Trials
- 1